Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.

Kos, Zuzana; Roblin, Elvire; Kim, Rim S; Michiels, Stefan; Gallas, Brandon D; Chen, Weijie; van de Vijver, Koen K; Goel, Shom; Adams, Sylvia; Demaria, Sandra; Viale, Giuseppe; Nielsen, Torsten O; Badve, Sunil S; Symmans, W Fraser; Sotiriou, Christos; Rimm, David L; Hewitt, Stephen; Denkert, Carsten; Loibl, Sibylle; Luen, Stephen J; Bartlett, John M S; Savas, Peter; Pruneri, Giancarlo; Dillon, Deborah A; Cheang, Maggie Chon U; Tutt, Andrew; Hall, Jacqueline A; Kok, Marleen; Horlings, Hugo M; Madabhushi, Anant; van der Laak, Jeroen; Ciompi, Francesco; Laenkholm, Anne-Vibeke; Bellolio, Enrique; Gruosso, Tina; Fox, Stephen B; Araya, Juan Carlos; Floris, Giuseppe; Hudecek, Jan; Voorwerk, Leonie; Beck, Andrew H; Kerner, Jen; Larsimont, Denis; Declercq, Sabine; Van den Eynden, Gert; Pusztai, Lajos; Ehinger, Anna; Yang, Wentao; AbdulJabbar, Khalid; Yuan, Yinyin

Kos, Zuzana; Roblin, Elvire; Kim, Rim S; Michiels, Stefan; Gallas, Brandon D; Chen, Weijie; van de Vijver, Koen K; Goel, Shom; Adams, Sylvia; Demaria, Sandra; Viale, Giuseppe; Nielsen, Torsten O; Badve, Sunil S; Symmans, W Fraser; Sotiriou, Christos; Rimm, David L; Hewitt, Stephen; Denkert, Carsten; Loibl, Sibylle; Luen, Stephen J; Bartlett, John M S; Savas, Peter; Pruneri, Giancarlo; Dillon, Deborah A; Cheang, Maggie Chon U; Tutt, Andrew; Hall, Jacqueline A; Kok, Marleen; Horlings, Hugo M; Madabhushi, Anant; van der Laak, Jeroen; Ciompi, Francesco; Laenkholm, Anne-Vibeke; Bellolio, Enrique; Gruosso, Tina; Fox, Stephen B; Araya, Juan Carlos; Floris, Giuseppe; Hudecek, Jan; Voorwerk, Leonie; Beck, Andrew H; Kerner, Jen; Larsimont, Denis; Declercq, Sabine; Van den Eynden, Gert; Pusztai, Lajos; Ehinger, Anna; Yang, Wentao; AbdulJabbar, Khalid; Yuan, Yinyin.

Afiliación

Kos Z; Department of Pathology, BC Cancer - Vancouver, Vancouver, BC Canada.
Roblin E; 2Department of Biostatistics and Epidemiology, Gustave Roussy, University Paris-Saclay, Villejuif, France.
Kim RS; 3Oncostat U1018, Inserm, University Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif, France.
Michiels S; 4National Surgical Adjuvant Breast and Bowel Project (NSABP)/NRG Oncology, Pittsburgh, PA USA.
Gallas BD; 2Department of Biostatistics and Epidemiology, Gustave Roussy, University Paris-Saclay, Villejuif, France.
Chen W; 3Oncostat U1018, Inserm, University Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif, France.
van de Vijver KK; 5Division of Imaging, Diagnostics, and Software Reliability (DIDSR); Office of Science and Engineering Laboratories (OSEL); Center for Devices and Radiological Health (CDRH), US Food and Drug Administration (US FDA), Silver Spring, MD USA.
Goel S; 5Division of Imaging, Diagnostics, and Software Reliability (DIDSR); Office of Science and Engineering Laboratories (OSEL); Center for Devices and Radiological Health (CDRH), US Food and Drug Administration (US FDA), Silver Spring, MD USA.
Adams S; 6Department of Pathology, University Hospital Antwerp, Antwerp, Belgium.
Demaria S; 7Department of Pathology, Ghent University Hospital, Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Viale G; 8The Sir Peter MacCallum Cancer Centre, Melbourne, VIC Australia.
Nielsen TO; 9Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria Australia.
Badve SS; 10Perlmutter Cancer Center, New York University Medical School, New York, NY USA.
Symmans WF; 11Departments of Radiation Oncology and Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY USA.
Sotiriou C; 12Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan, Italy.
Rimm DL; 13Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
Hewitt S; 14Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, USA.
Denkert C; 15Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX USA.
Loibl S; 16Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
Luen SJ; 17Department of Pathology, Yale School of Medicine, New Haven, CT USA.
Bartlett JMS; 18Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, MD USA.
Savas P; 19Institute of Pathology, Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg and Philipps-Universität Marburg, Marburg, Germany.
Pruneri G; 20German Breast Group, Neu-Isenburg, Germany.
Dillon DA; 9Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria Australia.
Cheang MCU; 21Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC Australia.
Tutt A; 22Ontario Institute for Cancer Research, Toronto, ON Canada.
Hall JA; 23University of Edinburgh Cancer Research Centre, Edinburgh, UK.
Kok M; 9Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria Australia.
Horlings HM; 21Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC Australia.
Madabhushi A; 24Department of Pathology, IRCCS Fondazione Instituto Nazionale Tumori and University of Milan, School of Medicine, Milan, Italy.
van der Laak J; 25Department of Pathology, Brigham and Women's Hospital, Boston, MA USA.
Ciompi F; 26Department of Pathology, Dana Farber Cancer Institute, Boston, MA USA.
Laenkholm AV; 27Institute of Cancer Research Clinical Trials and Statistics Unit, The Institute of Cancer Research, Surrey, UK.
Bellolio E; 28Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
Gruosso T; Vivactiv Ltd, Bellingdon, Bucks, UK.
Fox SB; 30Department of Medical Oncology and Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Araya JC; 6Department of Pathology, University Hospital Antwerp, Antwerp, Belgium.
Floris G; 31Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Hudecek J; 32Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH USA.
Voorwerk L; 33Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH USA.
Beck AH; 34Computational Pathology Group, Department of Pathology, Radboud University Medical Center, Nijmegen, Netherlands.
Kerner J; 34Computational Pathology Group, Department of Pathology, Radboud University Medical Center, Nijmegen, Netherlands.
Larsimont D; 35Department of Surgical Pathology Zealand University Hospital, Køge, Denmark.
Declercq S; 36Departamento de Anatomía Patológica, Universidad de La Frontera, Temuco, Chile.
Van den Eynden G; Forbius, Montreal, QC Canada.
Pusztai L; 8The Sir Peter MacCallum Cancer Centre, Melbourne, VIC Australia.
Ehinger A; 38Department of Pathology, Peter MacCallum Cancer Centre Department of Pathology, Melbourne, VIC Australia.
Yang W; 39Department of Pathology, Universidad de la Frontera, Temuco, Chile.
AbdulJabbar K; 40KU Leuven- Univerisity of Leuven, Department of Imaging and Pathology, Laboratory of Translational Cell & Tissue Research and KU Leuven- University Hospitals Leuven, Department of Pathology, Leuven, Belgium.
Yuan Y; 41Department of Research IT, The Netherlands Cancer Institute, Amsterdam, The Netherlands.